Arthroscopic intra-articular cranial cruciate ligament reconstruction with a synthetic implant yields satisfactory midterm outcome in 15 large-breed dogs
American Journal of Veterinary Research · 2026
DOI: 10.2460/ajvr.25.07.0259 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2026. Verfasst von Sven Ödman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Animal ArtroClinic i Söderköping AB, Söderköping, Sweden. Hauptthemen laut MEDLINE: Arthroscopy, Anterior Cruciate Ligament Injuries, Dog Diseases, Anterior Cruciate Ligament. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
To report the midterm clinical outcome of synthetic IA reconstruction of the cranial cruciate ligament (CrCL) in dogs. Animals 16 cases of CrCL rupture in 15 client-owned dogs treated from November 2022 through June 2023 at a single referral center were retrospectively identified through nonrandom, criterion-based sampling. Skeletally mature dogs weighing more than 30 kg, surgically treated with IA CrCL arthroscopic reconstruction, with a 6-month orthopedic and radiographic follow-up, were included in this study. Clinical Presentation Dogs were referred with clinical signs (hind limb lameness, pain, positive direct and indirect drawer tests) of CrCL rupture.
Results
Median age was 5.3 years (range, 1.9 to 8.7), and median weight was 40.7 kg (range, 31.5 to 65.5). Twelve ruptures were acute, 4 were chronic, 14 were complete, and 2 were partial. All cases underwent arthroscopic IA CrCL reconstruction with an ultra-high-molecular-weight polyethylene (UHMWPE) implant secured with 1 femoral and 1 tibial interference screw placed in bone tunnels. Meniscal tears, identified in 9 cases, were debrided. Four postoperative complications occurred (2 infections, 1 recurrence of pain and lameness, and 1 implant slippage associated with meniscal tear). Revision surgery was required only in 1 case, whereas the rest of the complications were managed medically. After 6 months postoperatively, full functional recovery was achieved in 14 cases and deemed acceptable in 2. Thirteen cases showed satisfactory stifle stability. Osteoarthritis progressed slightly radiographically. No dogs required medical pain management. Clinical Relevance This IA UHMWPE reconstruction may be a viable alternative for CrCL rupture in large dogs. Long-term studies are needed to confirm these promising results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Animal ArtroClinic i Söderköping AB, Söderköping, Sweden.
- Centre Hospitalier Vétérinaire Massilia, Marseille, France.
- VetEchoChir, Villaz, France.
- ICE Research Unit, UPSP 2016-A104, VetAgro Sup, Lyon University, Marcy l'Etoile, France.
- Small Animal Surgery Department, VetAgro Sup, Lyon University, Marcy l'Étoile, France.
Zitieren
APA
Ödman, S., Martenne-Duplan, A., Finck, M., Buttin, P., Viguier, E., Cachon, T., & Julinder, K. (2026). Arthroscopic intra-articular cranial cruciate ligament reconstruction with a synthetic implant yields satisfactory midterm outcome in 15 large-breed dogs. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.25.07.0259
Vancouver
Ödman S, Martenne-Duplan A, Finck M, Buttin P, Viguier E, Cachon T, et al. Arthroscopic intra-articular cranial cruciate ligament reconstruction with a synthetic implant yields satisfactory midterm outcome in 15 large-breed dogs. American Journal of Veterinary Research. 2026. doi:10.2460/ajvr.25.07.0259
BibTeX
@article{dman2026,
author = {Ödman, Sven and Martenne-Duplan, Antonin and Finck, Marlène and Buttin, Philippe and Viguier, Eric and Cachon, Thibaut and Julinder, Krister},
title = {Arthroscopic intra-articular cranial cruciate ligament reconstruction with a synthetic implant yields satisfactory midterm outcome in 15 large-breed dogs},
journal = {American Journal of Veterinary Research},
year = {2026},
doi = {10.2460/ajvr.25.07.0259}
}
EUVIMED